Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency
9.8.1 Drugs used in metabolic disorders - View Category
Restrictions:
This is an orphan product and restricted to specialist initiation.
Prescribing Notes:
Available granule formulations are not dose equivalent and are not interchangeable and should be prescribed by brand name to avoid confusion.
16.2 Specific antidotes - View Category
8.4 Drugs for cytotoxic-induced side effects - View Category
Restrictions:
Restricted to specialist use only for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to <18 years of age with localised, non-metastatic, solid tumours.
4.8.1 Control of the epilepsies - View Category
Restrictions:
Restricted to specialist initiation only.
Prescribing Notes:
Children exposed to valproate in utero are at high risk of developmental disorder and congenital malformations. For further information and communication materials for prescribers to use in their discussions with patients, see MHRA guidance here.
Valproate should NOT be used routinely in women of child-bearing age for the treatment of Bipolar Disorder. If it is deemed clinically necessary, then all aspects of the prevent programme MUST be followed and documented.
7.3.5 Emergency contraception - View Category
Prescribing Notes:
- Ulipristal is licensed for use in women presenting up to 120 hours after unprotected intercourse for whom the insertion of an IUD is not acceptable.
- Please follow the CoSRH guidance for appropriate use.
7.3.5 Emergency contraception - View Category
7.4.3 Drugs used in urological pain - View Category
Restrictions:
Restricted to specialist initiation for the treatment of bladder pain syndrome characterised by either glomerulations or Hunner's lesions in adults with moderate to severe pain, urgency and frequency of micturition where other treatment options have failed, are not tolerated or are not appropriate.